Article History
Received: 17 May 2022
Accepted: 22 May 2023
First Online: 29 June 2023
Declarations
:
: Not applicable.
: Written informed consent was obtained from the patient’s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: JS has been reimbursed expenses to attend the PNS meeting, by a drug company. JG is an Expert Advisor for Alnylam, Ionis, Eidos, Intellia, and Pfizer.